What should investors do? Glenmark's share price has de-grown by ~0.7x over the past five years (from ~| 856 in July 2016 to ~| 607 levels in July 2021). In India, it is the market leader in dermatology and improving its presence in respiratory, CVS, anti-infectives and anti-diabetics, in particular. It has also forayed into consumer health segment focusing on Rx-OTC switch products...